SCHEMBL26220105

SCHEMBL26220105

C[C@@]1(O)CCN[C@@H](Cc2ccc(Cl)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.42
CHIT1 Q13231 2/20 0.39
KCNH2 Q12809 1/20 0.39
DRD2 P14416 1/20 0.35
LTA4H P09960 2/20 0.35
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.33
HSD11B1 P28845 1/20 0.33
PPARG P37231 1/20 0.33
CCR5 P51681 1/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
SLC6A4 P31645 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22903708 1.00 TRPA1 (0.42) TRPA1CHIT1KCNH2DRD2LTA4H
SCHEMBL22901884 1.00 TRPA1 (0.42) TRPA1CHIT1KCNH2DRD2LTA4H
Hydrochloric Acid SCHEMBL28702285 0.99 TRPA1 (0.41) TRPA1CHIT1KCNH2DRD2LTA4H
SCHEMBL18589425 0.85 TRPA1 (0.41) TRPA1CHIT1KCNH2DRD2ALDH1A1
SCHEMBL18609377 0.85 TRPA1 (0.41) TRPA1CHIT1KCNH2DRD2ALDH1A1
SCHEMBL25384636 0.80 LTA4H (0.36) TRPA1LTA4HALDH1A1POLB
SCHEMBL26220048 0.80 LTA4H (0.36) TRPA1LTA4HALDH1A1POLB
Trifluoroacetic Acid SCHEMBL18577478 0.75 TRPA1 (0.42) TRPA1CHIT1DRD2ALDH1A1
SCHEMBL21565752 0.70 POLB (0.47) LTA4HALDH1A1POLB
SCHEMBL1443794 0.69 POLB (0.61) LTA4HPOLBCHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278996-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE S.A. (PL) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278996-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS CHI3L1, CHI3L2, CHIA TRPA1 3735/4885CHIT1 4/4885KCNH2 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.